stella
beta
A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A — Stella
Recruiting
Back to Hemophilia A trials
Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations
(2 sites)
Japan
Nara Medical University Hospital, Kashihara-shi, Nara
Tokyo Medical University Hospital, Shinjuku-Ku, Tokyo
View full record on ClinicalTrials.gov